## EXPE: Expedia Group, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.74 indicates fundamental undervaluation. Quality metrics strong (ROE 54%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.9% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($247.61)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Brown Advisory Inc. Reduces Stake in Expedia Group, Inc. $EXPE**
- Source: MarketBeat | 20251209T093139 | Somewhat-Bullish | Relevance: 99%
-  Brown Advisory Inc. significantly reduced its stake in Expedia Group, Inc. by 23.8% in Q2, divesting 9,522 shares, though its remaining 30,545 shares are still valued at over $5 million. This reduction comes amidst insider selling by Director Madhumita Moina Banerjee and CAO Lance A. Soliday, yet other institutional investors have mostly increased their positions. Despite these changes, Expedia continues to perform well, beating quarterly earnings expectations and declaring a $0.40 quarterly dividend.

**2. Expedia Group, Inc. $EXPE Shares Sold by Lido Advisors LLC**
- Source: MarketBeat | 20251206T111950 | Somewhat-Bullish | Relevance: 98%
-  Lido Advisors LLC significantly decreased its stake in Expedia Group, Inc. (NASDAQ:EXPE) by 88.7% in Q2, selling 38,757 shares and retaining 4,921 shares valued at approximately $830,000. Expedia recently exceeded quarterly earnings estimates with $7.57 EPS and $4.41 billion in revenue, leading to a consensus analyst price target of about $265. The company also declared a quarterly dividend of $0.40 per share, while insiders have sold a total of 4,849 shares worth approximately $1.28 million over the last 90 days.

**3. Baird Financial Group Inc. Cuts Stock Position in Expedia Group, Inc. $EXPE**
- Source: MarketBeat | 20251207T082432 | Somewhat-Bullish | Relevance: 98%
- Baird Financial Group Inc. reduced its stake in Expedia Group by 3% in Q2, though other major institutions increased their holdings, with institutional ownership now at 90.76%. Company insiders have been net sellers, disposing of over $1.2 million in shares in the last 90 days. Despite insider selling, Expedia beat earnings expectations, declared a dividend, and received increased price targets from several analysts, maintaining a "Hold" consensus rating.

**4. Natixis Increases Holdings in Expedia Group, Inc. $EXPE**
- Source: MarketBeat | 20251208T122111 | Bullish | Relevance: 98%
- Natixis significantly increased its stake in Expedia Group, Inc. by 1,175.3% in Q2, boosting its holdings to 166,372 shares valued at approximately $28.06 million. The online travel company also reported strong quarterly results, beating EPS and revenue estimates, and declared a $0.40 quarterly dividend. Despite various analyst target price increases, the stock maintains a consensus "Hold" rating with an average target of $265.31.

**5. Ardmore Road Asset Management LP Sells 165,000 Shares of Expedia Group, Inc. $EXPE**
- Source: MarketBeat | 20251207T083032 | Somewhat-Bullish | Relevance: 98%
-  Ardmore Road Asset Management LP significantly reduced its stake in Expedia Group, Inc. by selling 165,000 shares, decreasing its position by 86.8% in the second quarter. Following the sale, the firm now owns 25,000 shares valued at $4.217 million. This comes amidst other institutional investors either buying new positions or boosting their existing stakes in the online travel company.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Mizuho | $270 | $240 | +12% |
| 2025-11-11 | Citigroup | $281 | $206 | +36% |
| 2025-11-10 | Argus Research | $300 | $265 | +13% |
| 2025-11-10 | Susquehanna | $265 | $200 | +32% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Mizuho | main | Neutral |
| 2025-11-11 | Citigroup | main | Neutral |
| 2025-11-10 | Argus Research | main | Buy |
| 2025-11-10 | Susquehanna | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 10 ($1.50M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-0.7%)
- Blackrock Inc.: 8.4% (-2.5%)
- JPMORGAN CHASE & CO: 8.2% (+168.5%)
- State Street Corpora: 4.8% (-2.4%)
- Windacre Partnership: 3.1% (+9.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 4 raises (avg +24%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.74 indicates undervaluation relative to growth. Forward P/E 14.8x attractive for 18% earnings growth. Quality metrics strong (ROE 54%). Analyst sentiment positive (4 raises, avg +24%). Insider selling cluster ($1.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.7B |
| Beta | 1.44 |
| 52W Range | $130.01 - $279.61 |
| Short Interest | 6.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.74 |
| Forward P/E | 14.8 |
| Current P/E | 17.5 |
| YoY Growth | 17.6% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 3.9% to 0.9% (-2.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.1pp (needs >4.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.94% (CS: 63) | Neutral |
| RSI_14 | 62.0 | Neutral |
| MACD Histogram | 0.11 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.128x | Above |
| vs SMA200 | 1.362x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $264.41
- **Stop Loss:** $247.61 (6.4% risk)
- **Target:** $298.01 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 29
- **Position Value:** $7,667.89
- **Portfolio %:** 7.67%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-05 (Est: $3.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.95 | $7.57 | +9.0% |
| 2025Q2 | $4.13 | $4.24 | +2.6% |
| 2025Q1 | $0.36 | $0.40 | +11.5% |
| 2024Q4 | $2.10 | $2.39 | +14.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*